INDEMNIFICATION AGREEMENTIndemnification Agreement • October 4th, 2010 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • British Columbia
For good and valuable consideration, the receipt and sufficiency of which each party acknowledges, the parties agree as follows:
FORBEARANCE AGREEMENTForbearance Agreement • October 4th, 2010 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
This FORBEARANCE AGREEMENT (this “Agreement”) is made and entered into as of September 30, 2010, by and among ANGIOTECH PHARMACEUTICALS, INC., a corporation organized under the laws of the Province of British Columbia, Canada (“Parent”), each of Parent’s Subsidiaries identified as a “Borrower” on the signature pages hereof (such Subsidiaries, each a “Borrower”, and collectively, jointly and severally, the “Borrowers”), the Lenders (as defined in the Credit Agreement referred to below) listed on the signature pages hereof and WELLS FARGO CAPITAL FINANCE, LLC, a Delaware limited liability company formerly known as Wells Fargo Foothill, LLC, in its capacity as arranger and administrative agent (“Agent”) for the Lenders.
